Linezolid for the treatment of postneurosurgical infection caused by methicillin-resistant Staphylococcus.
Conclusion: Our results suggest that linezolid as an alternative to vancomycin for the treatment of PNSI caused by MRS with a high rate of efficacy.
PMID: 31819809 [PubMed]
Source: Surgical Neurology International - Category: Neurosurgery Tags: Surg Neurol Int Source Type: research
More News: Brain | Coccidioidomycosis (Valley Fever) | Laboratory Medicine | Linezolid | Men | Meningitis | Microbiology | MRSA | Neurology | Neurosurgery | Staphylococcus Aureus | Study | Zyvox